ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 489,35
0,59%
Dow Jones
42 703,80
-0,01%
DAX
20 340,57
0,65%
Brent Oil
77,035
1,21%
Bitcoin
97 087,31
-5,08%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Daiichi Sankyo Co Ltd (PK) (DSKYF) Cours

Daiichi Sankyo Co Ltd (PK)

Daiichi Sankyo Co Ltd (PK) (DSKYF)

USOTC
26,20
-2,64
( -9,15% )
Mis à jour : 18:52:52
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
26,20
Prix Achat
25,80
Prix Vente
28,75
Volume échangé
19 108
25,80 Fourchette du Jour 28,84
25,45 Plage de 52 semaines 44,64
Cap du marché
50,22B
Clôture Veille
28,84
Ouverture
25,96
Dernière Transaction
55
@
26.2
Dernière heure de transaction
19:08:52
Volume financier
US$ 503 720
VWAP
26,3617
Volume moyen (3 m)
13 059
Actions en circulation
1 916 787 029
Rendement du Dividende
18,061.20%
Ratio Cours sur Bénéfices
0,28
Bénéfice par action (BPA)
104,72
Chiffre d'affairess
1,63T
Bénéfice net
200,73B

À propos de Daiichi Sankyo Co Ltd (PK)

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Biolog/vaccines
Site Web
www.daiichisankyo.co.jp
Siège social
Chuo, Tokyo, Jpn
Fondé
2005
Daiichi Sankyo Co Ltd (PK) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker DSKYF. Le dernier cours de clôture d'Daiichi Sankyo (PK) était de US$28,84. Au cours de la dernière année, les actions de Daiichi Sankyo (PK) ont été négociées dans une fourchette de prix de US$ 25,45 à US$ 44,64.

Daiichi Sankyo (PK) compte actuellement 1 916 787 029 actions en circulation. La capitalisation boursière d'Daiichi Sankyo (PK) est de US$55,28 milliard. Daiichi Sankyo (PK) a un ratio cours/bénéfice (ratio PE) de 0.28.

DSKYF Dernières nouvelles

Plus de nouvelles

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

15 Avril 2015
PR Newswire (US)

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

01 Avril 2015
PR Newswire (US)

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...

28 Juin 2011
PR Newswire (US)

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...

04 Avril 2011
PR Newswire (US)

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fib

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...

01 Décembre 2010
PR Newswire (US)

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillatio

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...

01 Décembre 2010
PR Newswire (US)

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...

12 Octobre 2010
PR Newswire (US)

Patients with Hypertension at Risk Due to Physician Inertia

Patients with Hypertension at Risk Due to Physician Inertia - New Supporting Hypertension Awareness and Research Europe-wide (SHARE) Survey Reports Findings at the 20th Annual Society of the...

21 Juin 2010
PR Newswire (US)

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban - Innovative Once-Daily Oral Factor Xa Inhibitor Submitted for Approval in Japan PR Newswire TOKYO, April...

06 Avril 2010
PR Newswire (US)

Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs

Bolsters Company's Expertise in Areas of Oncology and Hematology PARSIPPANY, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc. (DSI) announced today that Jay M. Feingold, M.D., Ph.D...

11 Février 2010
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.040.15290519877726.1629.825.5868127.00644481CS
4-1.66-5.958363244827.8631.4925.452960727.36631163CS
12-5.6-17.610062893131.834.7525.451305928.3138921CS
26-10.93-29.437112846837.1344.6425.45726830.02599905CS
52-2.63-9.122441900828.8344.6425.451200031.11070826CS
1563.3514.660831509822.8544.6419.45862330.09620244CS
260-39.25-59.969442322465.4595.9617.61665229.83932349CS

DSKYF - Frequently Asked Questions (FAQ)

What is the current Daiichi Sankyo (PK) share price?
The current share price of Daiichi Sankyo (PK) is US$ 26,20
How many Daiichi Sankyo (PK) shares are in issue?
Daiichi Sankyo (PK) has 1 916 787 029 shares in issue
What is the market cap of Daiichi Sankyo (PK)?
The market capitalisation of Daiichi Sankyo (PK) is USD 55,28B
What is the 1 year trading range for Daiichi Sankyo (PK) share price?
Daiichi Sankyo (PK) has traded in the range of US$ 25,45 to US$ 44,64 during the past year
What is the PE ratio of Daiichi Sankyo (PK)?
The price to earnings ratio of Daiichi Sankyo (PK) is 0,28
What is the cash to sales ratio of Daiichi Sankyo (PK)?
The cash to sales ratio of Daiichi Sankyo (PK) is 0,03
What is the reporting currency for Daiichi Sankyo (PK)?
Daiichi Sankyo (PK) reports financial results in JPY
What is the latest annual turnover for Daiichi Sankyo (PK)?
The latest annual turnover of Daiichi Sankyo (PK) is JPY 1,63T
What is the latest annual profit for Daiichi Sankyo (PK)?
The latest annual profit of Daiichi Sankyo (PK) is JPY 200,73B
What is the registered address of Daiichi Sankyo (PK)?
The registered address for Daiichi Sankyo (PK) is 3-5-1 NIHONBASHI-HONCHO, CHUO-KU, CHUO, TOKYO, 103-8426
What is the Daiichi Sankyo (PK) website address?
The website address for Daiichi Sankyo (PK) is www.daiichisankyo.co.jp
Which industry sector does Daiichi Sankyo (PK) operate in?
Daiichi Sankyo (PK) operates in the PHARMACEUTICAL BIOLOG/VACCINES sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,008
(799 900,00%)
477
PLFXPulse Evolution Corporation (CE)
US$ 0,0003
(29 900,00%)
530
EATREastern Asteria Inc (CE)
US$ 0,0003
(29 900,00%)
3,59M
ZAAGZA Group Inc (PK)
US$ 0,0001
(9 900,00%)
50k
RBSHRebus Holdings Inc (CE)
US$ 0,0001
(9 900,00%)
402
FPWMCharlestowne Premium Beverages Inc (CE)
US$ 0,000001
(-100,00%)
1 000
CRGPCalissio Resources Group Inc (CE)
US$ 0,000001
(-99,75%)
28k
NEOMNeoMedia Technologies Inc (CE)
US$ 0,000001
(-99,50%)
736
NOXLNoxel Corp (CE)
US$ 0,000001
(-99,00%)
59,9k
TMGIMarquie Group Inc (PK)
US$ 0,000001
(-99,00%)
4,53M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0037
(-19,57%)
246,99M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0001
(-50,00%)
243,57M
ASIIAccredited Solutions Inc (PK)
US$ 0,0006
(20,00%)
169,13M
NSAVNet Savings Link Inc (PK)
US$ 0,0004
(-20,00%)
161,2M
TKMOTekumo Inc (PK)
US$ 0,00025
(-16,67%)
145,76M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
DSKYF
Daiichi Sankyo (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés